A randomization, multicenter, open-label trial comparing

Project: Research project

Description

A randomization, multicenter, open-label trial comparing chemotherapy plus trastumab plus pertuzumab versus chemotherapy plus trastuzumab emtasine plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer
StatusFinished
Effective start/end date7/1/1411/30/18

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint

Random Allocation
Breast Neoplasms
Drug Therapy
Therapeutics
pertuzumab
Trastuzumab